White House Plan On Drug-Resistant TB Still Pending
Center for Global Health Policy’s “Science Speaks”: Is plan for drug-resistant TB delayed amid cost concerns, while cost of delay goes unnoticed?
Antigone Barton, senior writer and editor of “Science Speaks,” discusses the pending White House plan on drug-resistant tuberculosis, writing, “Now, more than a month after the plan was set to be completed, and with the World Health Organization’s annual report on the global TB epidemic set to be released this week, the status of the plan remains a question…” (10/26).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.